Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Accurate coagulation testing starts with proper specimen preparation. Even small pre-analytic errors, such as underfilled tubes, hemolysis, or improper centrifugation, can compromise results and patient care.
Due to hurricane Ian, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.
In an effort to eliminate interpretation mistakes and in turn improve diagnosis and treatment options for patients who have kidney stones, a team of researchers from Mayo Clinic’s Department of Laboratory Medicine and Pathology recently conducted a 12-month study to determine whether the use of artificial intelligence-trained algorithms can find errors in manually reviewed and reported kidney stone composition results.
This week's research roundup features: Robotics in neurosurgery: current prevalence and future directions
Lisa Brown, quality specialist for Mayo Clinic Laboratories customer service, explains working "behind the scenes" when a client calls Mayo Clinic Laboratories with an inquiry, that call is typically picked up within 20 seconds by an agent from Mayo Laboratory Inquiry (MLI). There are no phone trees or automated menus to wade through before they reach an agent. Agents mind the phones 24/7, 365 days a year.
Topic highlights include: White House launches monkeypox research agenda, Mayo Clinic: collaborations, startups to drive innovation, Why the latest screening tests and treatments offer hope for ovarian cancer
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the Saving Access to Laboratory Services Act (SALSA), how it is designed to mitigate harmful effects of the Protecting Access to Medicare Act (PAMA), where the legislation stands today, and how to get involved in advocacy.
Connie Ohnstad is the supervisor for Mayo Clinic Laboratories Inventory, which includes Mayo Clinic Laboratories Packaging and Specimen Kit Orders (SKO). Connie wears many hats as a supervisor at MCL, and she has a long history with Mayo Clinic, which has employed several generations of Connie’s family. She takes pride in ensuring that every day she offers her best for her employees, patients, and clients.
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
This week's research roundup features: Into the future: a pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer
By collaborating with Mayo Clinic Laboratories, Morris Hospital & Healthcare Center has been able to expand complex and specialized lab testing in the communities they serve.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and CEO and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, they discuss Dr. Morice’s new role as CEO and president of Mayo Clinic Laboratories (MCL), his patient-centered vision for the future, and how MCL is leading positive changes in the diagnostics industry.
Topic highlights include: Mayo Clinic health system experts say mental health issues on the rise, New York declares a state of emergency over polio, U.S. reaches medical milestone with millionth organ transplant